Saint-Herb lain (France ), June 1 0, 2 02 2 – Valneva SE VALN VLA, a specialty vaccine company, today provides an update on its European inactivated whole-virus COVID-19 vaccine candidate VLA2001. Following receipt of the European Commission (EC)'s notice of intent to terminate the Advance Purchase Agreement (APA) 1, Valneva proposed a remediation plan, which is now subject to further discussion within the EC and among the participating member states.